DMII

Drugs Made In America Acquisition II Corp. DMII

NasdaqSmall CapFinancials

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$487.77M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/DMII

Loading ratio trend…

About Drugs Made In America Acquisition II Corp. (DMII): stock profile, AI score and financials

Drugs Made In America Acquisition II Corp. (DMII) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. DMII is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. DMII trades on the Nasdaq exchange and files with the SEC under CIK 2040475. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DMII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Drugs Made In America Acquisition II Corp. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2040475 →